RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
|
|
|
-
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Authors: Peter Caravan
Accounts of chemical research 2009 Jul 21 -
Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot.
Authors: Rachel M Wald, Idith Haber, Ron Wald, Anne Marie Valente, Andrew J Powell, Tal Geva
Circulation 2009 Mar 17
Thought leaders and organizations working on research involving gadolinium.
- Pharmacyclics
- National Cancer Institute (NCI)
- Oregon Health and Science University
- Children's Oncology Group
- Jonsson Comprehensive Cancer Center
- University of Warwick
- University of North Carolina at Chapel Hill
- UMR 5620 CNRS-Université Claude Bernard Lyon 1
- Massachusetts General Hospital and Harvard Medical School
- Harvard Medical School
-
Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
conditions: Metastatic Cancer
interventions: motexafin gadolinium ; radiation therapy
-
Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme
conditions: Brain and Central Nervous System Tumors
interventions: motexafin gadolinium ; radiation therapy
-
Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur
Science Centric. - January 22, 2010 -
Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur, study suggests
Eurekalert Medicine_health. - January 20, 2010
Community
Sven Macholl
-
No NextBio groups were found for “gadolinium”.
Be the first to start a group and share your interests with others within the NextBio community.
